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Abstract
The aim of the present study was to assess the anti-obesity effects of grape seed extract (GSE) supplement in C57BL/6J mice. Thirty mice were
divided into three groups; normal diet control group (ND), high fat diet control group (HD) and high fat diet plus grape seed extract supplemented 
group (HD+GSE). Results were as follows: 1. GSE supplement reduced the weight gain in mice fed high fat diets; epididymal and back fat weights
were lower compared to non-supplemented HD group. 2. Blood lipid concentrations were lower in the HD+GSE group than in the HD group.
Serum HDL-C concentrations were higher in the HD+GSE group compared with the other groups. 3. The concentrations of acid-insoluble acylcarnitines
(AIAC) in serum and liver were higher in the HD+GSE group than in the HD group. 4. GSE supplementation increased mRNA levels of lipolytic
genes such as carnitine palmitoyltransferase-1 (CPT-1) and decreased mRNA levels of lipogenic genes such as acetyl CoA carboxylase (ACC).
These findings suggest that grape seed extract supplements in high fat diet might normalize body weight, epididymal and back fat weights, lipid 
concentrations, and carnitine levels through controlling lipid metabolism. 
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Introduction6)
Obesity occurs when a controlled or regulated system fails to 
maintain energy balance, resulting in excess body fat storage. 
The obese population is increasing at an alarming rate throughout the 
world. Obesity causes many health problems, both independently 
and in association with other diseases (Formiguera & Canton, 
2004). In particular, it is associated with the development of 
chronic diseases, including hypertension, type 2 diabetes mellitus, 
cardiovascular disease, osteoporosis, and certain forms of cancer. 
In addition to promoting obesity, diets with a dense caloric 
content are associated with an increased risk for developing type 
2 diabetes (Petro et al., 2004). Animal models, in which obesity 
and type 2 diabetes are induced by feeding high caloric diet, 
are of increasing interest for developing new therapeutic 
strategies. Obesity is strongly associated with type 2 diabetes. 
The relative risk of developing diabetes increases by 25% for 
every 1 kg/m
2 increase in BMI above 22 kg/m
2 (Finer, 2006; 
James, 2004). Reducing body fat is a major health goal 
throughout the world and identifying functional foods that can 
help reduce body fat and meet other health needs has been the 
subject of numerous studies (Hasler, 2000); grape seeds are one 
of the functional ingredients of particular interest in recent years. 
Grape is one of the most commonly consumed fruits in the 
world. It has various biological functions, due to its rich 
polyphenol ingredients, most of which are contained in its seeds 
(60-70%) and skin (30%). However, large quantities of grape 
seed wastes are produced annually by the food processing 
industry-wine, juice etc (Yoo et al., 2004). Grape ingredients 
also have healthful properties. Phenolic bioflavanoids from grape 
seeds and skins are powerful antioxidants. In particular, grape 
seeds contain two-thirds of the phenols of the grape, 5-8% by 
weight. Catechin, epicatechin and epicatechin gallate, and gallic 
acid are the monomeric compounds identified in grape seeds. 
These, along with dimers, trimers and oligomers of catechin and 
epicatechin are referred to as procyanidins (Yilmaz & Toledo, 
2004). When used with either vitamins C or E, the extract 
possesses double the antioxidant capacity (Shi et al., 2003). 
Polyphenol in grape seeds have also been reported to have a 
variety of biological activities, including antioxidant, anti- 
thrombotic, and cardioprotective effects (Jang & Han, 2002; Sano 
et al., 2005; Pataki et al., 2002). 
However, little is known about the effects of grape seed 
extracts on obesity in diet-induced C57BL/6J mice. Therefore, 
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Table 1. Composition of experimental diets (AIN-93 modified diet for rodents)
Ingredient (g)
Normal diet
1) High fat diet
2)
DW
3) DW GSE
4)
Casein, lactic 200 200 200
L-cystine 3 3 3
Corn Starch 315 - -
Maltodextrin 35 125 125
Sucrose 350 68.8 68.8
Cellulose 50 50 50
Soybean Oil 25 25 25
Lard 20 245 245
Mineral Mix 10 10 10
Dicalcium Phosphate 13 13 13
Calcium Carbonate 5.5 5.5 5.5
Potassium Citrate 16.5 16.5 16.5
Vitamin Mix 10 10 10
Choline Bitarate 2 2 2
FD&C Yellow Dye #5 0.05 - -
FD&C Blue Dye #1 - 0.05 0.05
Total 1055.05 773.85 773.85
Kcal 4057 4057 4057
Kcal/g 3.8 5.2 5.2
Grape seed extract 
(oral admistration) DW DW 250 mg/kg BW
5)
1) AIN-93  Modified  diet  with  4%  fat  (10%  fat  calories)  content 
2) AIN-93  Modified  high  fat  diet  with  35%  fat  (60%  fat  calories)  content 
3) DW:  Distilled  water 
4) GSE:  Grape  seed  extract 
5) BW:  Body  weight 
this study was designed to investigate the effects of grape seed 
extracts on changes in body weight gain, feed intake, lipid 
profiles, carnitine levels, and mRNA expressions of enzymes 
related to lipid metabolism in C57BL/6J mice with high fat diet 
induced obesity. 
Materials and Methods
Materials 
Grape seed extract (GSE) (main components: oligomeric 
proanthocyanidin complexes (OPCs)) (Gabetta et al., 2000) were 
supplied by Korea Hanlim Co. (Hanlim, Korea). According to 
the manufacturer, this GSE contained more than 80 procyanidolic 
value, potential cyanidol chloride (7%), monomer (30%).
Animals and diets 
Male C57BL/6J mice, aged 4 weeks, were purchased from 
Charles River Laboratories (Tokyo, Japan). The animals were 
maintained on a pellet diet (Research Diets, New Brunswick, 
NJ, USA) for 1 week, and then randomly divided into three 
groups: normal diet (ND) group, high fat diet (HD) control group, 
and one experimental group fed a high fat diet with grape seed 
extract (HD+GSE). Each group consisted of ten mice. Control 
group mice were orally administered 1ml of distilled water and 
the other treatment group (HD+GSE) mice were orally 
administered 1 ml of each extract dissolved in distilled water 
at the dose of 250 mg/kg body weight. The compositions of the 
experimental diets (Research Diets, New Brunswick, NJ, USA) 
are shown in Table 1. The animals were housed in a temperature- 
controlled environment with a 12-hour light/dark cycle. The 
animals were given free access to food and water during the 
entire experimental period. The feed intake and body weight were 
measured daily and weekly, respectively. The experimental 
protocol was approved by the Animal and Use Committee of 
Chonbuk National University (n.07040). 
Collection of serum and tissue samples 
Feed was removed 12 hours before sacrificing. Blood samples 
were collected from each mouse by orbital/cardiac puncture and 
incubated on ice water for 1 hour. Serum was separated from 
the blood by centrifugation (Micro 17R, Vision Scientific Co., 
Seoul, Korea) at 1,100xg for 15 minutes at 4℃ and kept at -80℃ 
until analyzed. The liver, kidney, brain, back fat, muscle, and 
epididymal fat were removed, rinsed with a phosphate-buffered 
saline solution, wiped with a paper towel, weighed quickly, 
frozen in liquid nitrogen, and stored at -80℃ until assayed. 
Analysis of lipids in serum and liver 
Total cholesterol (TC) in the serum and liver tissue was 
measured by an enzymatic method using a commercial kit (Asan 
Pharmaceutical Co., Seoul, Korea), The triglyceride (TG) in the 
serum and liver tissue was enzymatically measured with a 
commercial kit (Asan Pharmaceutical Co., Seoul, Korea). The high 
density-lipoprotein cholesterol (HDL-C) fraction was determined 
by the dextran sulfate-Mg
++ method. 
Analysis of carnitine in serum and liver 
Liver tissues were homogenized by adding 50 mg of tissue 
to 1 ㎖ of 0.3M PCA, centrifuging at 1,500xg and separating 
the supernatant. Nonesterified carnitine (NEC), acid-soluble 
acylcarnitine (ASAC), and acid-insoluble acylcarnitine (AIAC) in 
serum and liver tissues were determined by the radioimmunoenzymatic 
procedure of Cederblad and Lindstedt (1972), as modified by 
Sachan  et al. (1984). A 100 ㎕ sample was hydrolyzed with 
200 ㎕ of 0.6M PCA, centrifuged at 1,500xg for 10min. Acid 
soluble acyl carnitine (ASAC) and non-esterified carnitine (NEC) 
were determined in the supernatant and acid insoluble acyl 
carnitine (AIAC) was determined in the pellet. A 150 ㎕ aliquot 
of the supernatant was neutralized with 1 M KHCO3 for 
measurement of NEC. In the ASAC assay, 100 ㎕ of supernatant 
was hydrolyzed with 0.5 N KOH and neutralized with 
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Table 2. Body weight and food intake in mice fed experimental diets for 
12weeks
Groups ND HD HD+GSE
Initial Weigh (g) 18.56 ± 0.56
1) 18.68 ± 0.42 18.43 ± 0.56
Final Weight (g) 23.81 ± 1.04
c2) 35.76 ± 2.08
a 28.22 ± 2.37
b
Weight gain (g)  5.55 ± 0.91
c 16.78 ± 2.01
a  9.76 ± 2.62
b
Feed intake (g/day)  2.20 ± 0.03
c  1.98 ± 0.04
a  1.76 ± 0.03
b
Energy intake (kcal/day)  8.36 ± 0.13
c 10.32 ± 0.04
a  9.15 ± 0.16
b
Mean ± SD  of  10  mice  per  group
Values with different superscripts are significantly different by ANOVA with Duncan's 
multiple  range  test  at  p<0.05.
ND: Normal diet, HD: High fat diet, HD+GSE: High fat diet plus grape seed extract
Fig. 1. Adipose tissue mass of mice fed experimental diets for 12weeks. Mean
± SD  of  10  mice  per  group.  Values  with  different  superscripts  are  significantly 
different by ANOVA with Duncan's multiple range test at p<0.05. ND: Normal diet, 
HD:  High  fat  diet,  HD+GSE:  High  fat  diet  plus  grape  seed  extract
with 0.6 M PCA and drained, hydrolyzed in 0.5 N KOH for 
60min in a water bath at 60℃, and neutralized with PCA/ 
MOPS-I. The reaction mixture containing 1 M MOPS buffer, 
0.1 M potassium ethyleneglycoltetraacetate, 0.1 M sodium tetra-
thionate, 0.1 mM [1-C
14] acetyl CoA solution (Amersham, Little 
Chalfont, Buckinghamshire, England) was added to the supernatant 
in each sample, and reacted with 1 unit of carnitine acetyltrans-
ferase (Sigma Chemical Co., St. Louis, MO, USA) in a water 
bath at 37℃ for 30min. 200 ㎕ of reacted supernatant was passed 
through a column with ion exchange resin (AG 1x8, 200-400 
mesh), which collected the unreacted [1-C
14] acetyl carnitine, and 
the C
14 isotope was measured in a Beckman LS-3801 liquid 
scintillation counter (Beckman Instruments, Palo Alto, CA, 
USA). Total carnitine was calculated as the sum of NEC, ASAC, 
and AIAC values. 
mRNA levels of ACS, CPT-I and ACC in liver 
Total RNA was extracted with Trizol reagent. The concentration 
was confirmed with a spectrophotometer, and RT-PCR was 
performed using a one-step RT-PCR kit (ABgene, USA) for 
cDNA synthesis on a RT-PCR machine (MWG-BIOTECH, PRIMUS), 
and β-actin cDNA was also prepared as a control. The reaction 
finished and cDNA product was confirmed by 1.5% agarose gel 
electrophoresis. We confirmed gene expressions on acyl-CoA 
synthetase (ACS), carnitine palmitoyl transferase-I (CPT-I), and 
acetyl-CoA carboxylase (ACC). The relative intensity of all 
mRNAs was analyzed by using the AlphaEaseFC software 
(Alpha Innotech Corporation, San Leandro, CA, USA). 
Statistical analysis 
All values are expressed as mean ± standard deviation. The 
data were analyzed by one-way ANOVA using Statistical 
Package for Social Science (SPSS) version 16.0.1 program, and 
the differences among groups were assessed using Duncan’s 
multiple range test. Statistical significance was considered at p<0.05. 
Results 
Weight gain and feed efficiency 
As shown in Table 2, there were no significant differences 
in initial body weight among the groups. Final body weight and 
weight gain of the HD+GSE group was significantly lower than 
those of the HD group. Feed intake was significantly lower in 
the HD+GSE group compared to the HD group. Energy intake 
was significantly lower in the HD+GSE group compared to the 
HD group. In this study, weight loss of the HD+GSE group is 
involved in reduction of feed intake and energy intake. These 
results indicate a possibility that GSE supplementation have 
feeding control regulation. 
Adipose tissue mass in mice 
As presented in Fig. 1., epididymal fat weight was significantly 
decreased in the HD+GSE group compared to the HD group. 
Back fat weight was also decreased significantly in the HD+GSE 
group compared to the HD group. These data showed that GSE 
supplementation reduces adipose tissue mass. In this study, 
weight loss of HD+GSE group is due to the reduction of body 
fat mass. 
Serum and liver lipid levels 
The effects of GSE supplementation on lipid concentrations 
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Table 3. Lipid concentrations in serum and liver (mg/dl) 
Groups ND HD HD+GSE
Serum
Triglyceride  54.39 ± 4.02
c  94.07 ± 7.36
a  79.17 ± 3.91
b
Total Cholesterol 139.28 ± 5.70
c 176.97 ± 7.88
a 158.75 ± 17.09
b
HDL-Cholesterol  74.48 ± 3.71
b  58.88 ± 6.33
b  85.19 ± 5.44
a
Liver
Triglyceride  28.15 ± 4.27
b  37.04 ± 5.07
a  32.37 ± 3.64
b
Total cholesterol   6.73 ± 0.40
b   8.98 ± 0.73
a  5.37 ± 0.58
c
Mean ± SD  of  10  mice  per  group 
Values with different superscripts are significantly different by ANOVA with Duncan's 
multiple  range  test  at  p<0.05.
ND: Normal diet, HD: High fat diet, HD+GSE: High fat diet plus grape seed extract
Table 4. Carnitine concentrations in serum and liver (mg/dl) 
Groups ND HD HD+GSE
Serum (μmol/dl)
NEC   0.48 ± 0.04   0.47 ± 0.10   0.57 ± 0.09
ASAC   1.38 ± 0.29
b   0.85 ± 0.21
a   1 . 0 9±0 .1 7
a
AIAC   0.35 ± 0.05
a   0.18 ± 0.02
b   0 . 3 7±0 .0 6
a
TCNE   2.21 ± 0.31
a   1.71 ± 0.18
b   2 . 0 4±0 .1 6
ab
Acyl/Free (%)   3.40 ± 0.51
a   2.15 ± 0.53
b   2 . 3 8±0 .4 2
b
Liver (nmol/g)
NEC 143.06 ± 9.83
a 107.65 ± 13.91
c 121.33 ± 10.46
b
ASAC  55.88 ± 15.24  41.16 ± 14.12  50.89 ± 10.22
AIAC   5.42 ± 2.38
b   3.98 ± 0.75
b   7 . 8 8±1 .0 3
a
TCNE 201.84 ± 20.08
a 154.93 ± 23.68
b 179.66 ± 19.54
ab
Acyl/Free (%)   0.43 ± 0.07   0.39 ± 0.10   0.51 ± 0.09
Mean ± SD  of  10  mice  per  group 
Values with different superscripts are significantly different by ANOVA with Duncan's 
multiple  range  test  at  p<0.05. 
ND: Normal diet, HD: High fat diet, HD+GSE: High fat diet plus grape seed extract 
ACS
CPT-I
ACC
Fig. 2. Hepatic gene expressions. Mean ± SD of 10 mice per group. Values with 
different  superscripts  are  significantly  different  by  ANOVA  with  Duncan's  multiple 
range test at p<0.05. ND: Normal diet, HD: High fat diet, HD+GSE: High fat diet 
plus  grape  seed  extract
(TG) was significantly lower in the HD+GSE group compared 
to the HD group. Serum total cholesterol (TC) was significantly 
higher in the HD group than in the other groups. Serum 
HDL-cholesterol and HDL-cholesterol/total cholesterol (TC) 
ratio were significantly higher in the HD+GSE group compared 
to the other groups. Liver triglyceride (TG) and total cholesterol 
(TC) of HD+GSE group were significantly lower than those of 
the HD group. 
Serum and liver carnitine levels 
Carnitine concentrations of serum and liver are shown in Table 
4. The NEC concentrations in serum were highest in the 
HD+GSE group. The ASAC concentrations of the HD group 
were lowest. AIAC concentrations were significantly higher in 
the ND and HD+GSE group, and lowest in the HD group. TCNE 
concentrations were highest in the ND group and lowest in the 
HD group. The acyl/free ratio was highest in the ND group and 
was significantly lower in the HD and HD+GSE groups. Hepatic 
NEC concentrations were significantly higher in the ND group. 
The ASAC concentrations were not different among the groups. 
The concentrations of AIAC were highest in the HD+GSE group 
and lowest in the HD group. The hepatic TCNE concentrations 
were significantly higher in the ND group and lower in the HD 
group. The acyl/free ratio was not different among the groups. 
mRNA levels of ACS, CPT-I and ACC in liver 
Hepatic gene expressions are shown in Fig. 2. Acyl-CoA 
synthetase (ACS) mRNA expressions were not significantly 
different between the HD and HD+GSE group. However, ACS 
mRNA expressions were lower in the ND group than in other 
groups. Carnitine palmitoyl transferase-I (CPT-I) expression was Su-Hui Park et al. 231
slightly, but significantly, higher in the HD+GSE group than in 
the other groups. Acetyl-CoA carboxylase (ACC) was 
significantly higher in the HD group than in other groups, and 
significantly lower in the HD+GSE group than in other groups. 
Discussion 
A variety of naturally occurring grape seed extracts (GSE) have 
been found to have beneficial effects on health, and these 
compounds have drawn attention because of their relative 
safeness and accumulated evidence of physiological properties, 
antioxidant efficacy, and anti-diabetic effects in animals and 
humans (Bagchi et al., 2000; Pinent et al., 2004; Yamakoshi 
et al., 2002). In this study, the antiobesity effects of GSE were 
investigated by evaluating body weight gain and feed intake, fat 
weight, and lipid and carnitine concentrations in serum and liver, 
as well as mRNA expressions in livers of high-fat diet-induced 
obese C57BL/6J mice. We used GSE at doses of 250 mg/kg/d 
to demonstrate the antiobesity effects of GSE. 
High-energy diets are used widely and have been accepted in 
nutritional experiments as a good strategy to induce overweight 
conditions and fat deposition in animals (Kim et al., 2000). Thus, 
a prolonged period of high-energy feeding induces a marked 
weight increase in mice. In this study, HD feeding for 12 weeks 
resulted in obesity, which was associated with increased body 
weight and fat mass with development of hyperlipidemia. 
Although initial body weights of mice did not differ among the 
groups, final weight in the HD+GSE group was 6.65 g lower 
than that in the high-fat diet group, and feed intake and energy 
intake were reduced by 0.22 g and 1.17g, respectively, compared to 
the HD group. Dietary supplementation of GSE (proanthocyanidin) 
has been reported to have no significant does-independent effects 
in Sprague-Dawley rats (Kim et al., 2004). However, epididymal 
fat and back fat pad depositions were significantly lower in the 
HD+GSE group compared with the HD group. Thus, supple-
mentation with GSE significantly reduced body weight, feed 
intake and adipose tissue mass in this study. 
Additionally, triglyceride and total cholesterol concentrations 
in serum and liver were significantly lower in the HD+GSE group 
compared with the HD group. In this study, GSE supplementation 
decreased triglyceride and total cholesterol concentrations in 
serum and liver, and increased serum HDL-cholesterol and 
HDL-cholesterol/triglyceride ratio concentrations. Vinson et al. 
(2002) reported a significant dose-dependent reduction in serum 
total cholesterol (TC) and triglyceride (TG) concentrations in an 
atherosclerosis model supplemented with GSE. 
Carnitine (β-hydroxy-γ-trimethylammonium butyrate) is an 
essential metabolite, which has a number of indispensable roles 
in intermediary metabolism. Carnitine is transported from the 
liver to other organs after biosynthesis in the liver from the amino 
acids lysine and methionine. Carnitine has an important role in 
the transport of activated long-chain fatty acids from the cytosol 
to the mitochondrial matrix, where β-oxidation takes place. 
Carnitine is involved in the transfer of the products of 
peroxisomal β-oxidation, including acetyl-CoA, to the mitochon-
dria for oxidation in Krebs cycle (Bieber, 1988; Vaz & Wanders, 
2002). This means that a lack of carnitine will slow oxidation 
of fatty acids and fuel an increase in serum lipid levels. In this 
study, the NEC concentrations in serum were significantly higher 
in the HD+GSE group than in the ND and HD groups. ASAC 
and AIAC concentrations in serum were significantly lower in 
the HD group than in the ND group. Especially, the concentra-
tions of the carnitine fractions in serum were significantly higher 
in the HD+GSE (GSE administration) group than in the HD 
group. These changes resulted in a decreased acyl/free carnitine 
ratio in the HD group compared with the ND group. ASAC 
concentration and the acyl/free carnitine ratio in liver were not 
significantly different among groups. The AIAC concentration 
was significantly higher in the HD+GSE group than in the HD 
group. Mun et al. (2007) reported that the concentrations of 
carnitine fractions were significantly higher in the ND group than 
in the HD group. In our study, concentrations of carnitine 
fractions were significantly higher in the ND group than in the 
HD group. Carnitine concentrations in the blood and liver were 
increased in the GSE supplemented group. Thus, we assume that 
GSE administration increased β-oxidation of free fatty acids 
which were increased by high-fat dietary intake. 
In evaluating the differences in lipid metabolism with GSE 
supplementation, we measured the hepatic ACS, CPT-I, and ACC 
mRNA levels of mice that were fed ND, HD and HD with GSE. 
Long-chain fatty acyl-CoA synthetase (ACS), as the first enzyme 
for fatty acid metabolism, plays a key role in both synthesis of 
cellular lipids and degradation of fatty acids via β-oxidation 
(Suzuki  et al., 1990). Acyl-CoA synthetase (ACS) mRNA 
expressions were not significantly different between the HD and 
HD+GSE group. However, ACS mRNA expressions were lower 
in the ND group than in other groups. 
The expression levels of ACS may modulate the metabolic 
flux of acyl-CoA in the liver and adipose tissue that utilize fatty 
acids for the generation or storage of energy (Ryu et al., 2003). 
Carnitine palmitoyltransferase-I (CPT-I) is located on the outer 
mitochondrial membrane and facilitates the movement of the long 
chain fatty acid (LCFA) into mitochondrial matrix. Therefore, 
it functions as a rate-limiting enzyme of β-oxidation in the 
mitochondria by having a key role in the transport of LCFA 
(McGarry et al., 1978). In our results, the hepatic CPT-I mRNA 
levels in the mice were slightly, but significantly, higher in the 
HD+GSE group than in the other groups. Earlier studies reported 
that hepatic CPT-I mRNA expression is increased by high fat 
diet with kochujang supplementation, suggesting that the control 
of CPT-I mRNA expression is a key feature in the regulation 
of fatty acid oxidation (Koo et al., 2008). Another study reported 
that CPT-I enzyme activity was increased by the up-regulation 
of CPT-I transcription that was mediated by genistein, soy 
isoflavone, and daidzein (Shin et al., 2006). The present study 232 Grape seed extract on antiobesity in C57BL/6J mice
supports the results of these earlier studies by demonstrating 
increased hepatic CPT-I mRNA expression in the GSE 
supplemented group. Acetyl-CoA carboxylase (ACC), which 
catalyses an ATP dependent reaction is considered a synthesis 
pathway (Memon et al., 1999). The activity of ACC also 
modulates the rate of β-oxidation of fatty acid. Malonyl-CoA 
decreases the transport of LCFA acyl-CoA from cytoplasm to 
the mitochondrial matrix by inhibiting carnitine palmitoylacyl-
transferase I via an allosteric mechanism (McGarry et al., 1978). 
In our study, GSE supplementation decreased hepatic ACC 
mRNA levels. Malonyl-CoA, synthesized by ACC, is a potent 
CPT-I inhibitor as well as the first committed intermediate in 
the pathway of fatty acid biosynthesis (Bonnefont et al., 1999). 
These data support that high-fat diet or fasting causes a reduction 
in fatty acid synthesis by decreasing the synthesis of acetyl CoA 
carboxylase (Achouri et al., 2005). In this study, Fig. 2 showed 
that GSE supplement significantly increased hepatic lipolysis 
enzyme expression such as CPT-I, whereas significantly decreased 
lipogenic enzyme expression such as ACC. These results suggest 
that GSE supplementation decrease body fat weight by suppression 
of adipogenic enzyme such ACC and overexpression of lipolytic 
enzyme such as CPT-I. 
In conclusion, we have demonstrated that GSE has beneficial 
effects and reverses some of the negative effects of a high fat 
diet. It provided evidence that GSE supplementation decreases 
body weight gain, feed intake, TG and TC in serum and liver. 
The study observed significant differences in carnitine concentrations 
among carnitine fractions (NEC, ASAC, AIAC, TCNE). Although 
there were few differences in gene expressions, GSE supple-
mentation increased hepatic CPT-I mRNA concentrations above 
those of the ND group. GSE supplementation decreased hepatic 
ACC mRNA concentrations below those of the ND group. 
Finally, the effects of GSE on high-fat diet-induced obese mice 
indicate that grape seed extract possesses potential antiobesity 
effects and may relieve obesity-related symptoms, including 
hyperlipidemia, cardiovascular diseases and insulin resistance. 
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